According to the US Department of Labor (DoL) report on Thursday, the number of US citizens applying for …
Copyright ©2024 | All Rights Reserved.
LATEST NEWS
-
-
On Thursday, AUD/USD edges up by approximately 0.1% to reach the 0.6440s, extending the correction from the significant …
-
Forex
ECB’s Villeroy suggests that unless there’s a significant surprise, rate cuts are likely at the next meeting.
According to Reuters, French central bank chief and European Central Bank (ECB) policymaker Villeroy de Galhau indicated on …
-
Forex
The US Philadelphia Fed Manufacturing Index surges to 15.5 in April, surpassing expectations of 1.5.
The Diffusion Index for current general activity in the Federal Reserve Bank of Philadelphia’s Manufacturing Survey sharply increased …
-
Forex
The price of gold is benefiting from heightened tensions in the Middle East and a downturn in the value of the US dollar.
Gold prices (XAU/USD) rebound to $2,380 during Thursday’s early American session following losses on Wednesday. The precious metal …
-
Stocks
The bullish trendline for CRISPR Therapeutics stock has consistently proven reliable, never failing thus far.
Crispr Therapeutics AG (NASDAQ: CRSP) is currently down 2.8% at $56.35 this afternoon, extending a decline from its …
LATEST NEWS
-
According to the US Department of Labor (DoL) report on Thursday, the number of US citizens applying for …
-
On Thursday, AUD/USD edges up by approximately 0.1% to reach the 0.6440s, extending the correction from the significant …
-
Forex
ECB’s Villeroy suggests that unless there’s a significant surprise, rate cuts are likely at the next meeting.
According to Reuters, French central bank chief and European Central Bank (ECB) policymaker Villeroy de Galhau indicated on …
-
Forex
The US Philadelphia Fed Manufacturing Index surges to 15.5 in April, surpassing expectations of 1.5.
The Diffusion Index for current general activity in the Federal Reserve Bank of Philadelphia’s Manufacturing Survey sharply increased …
-
Forex
The price of gold is benefiting from heightened tensions in the Middle East and a downturn in the value of the US dollar.
Gold prices (XAU/USD) rebound to $2,380 during Thursday’s early American session following losses on Wednesday. The precious metal …
-
Stocks
The bullish trendline for CRISPR Therapeutics stock has consistently proven reliable, never failing thus far.
Crispr Therapeutics AG (NASDAQ: CRSP) is currently down 2.8% at $56.35 this afternoon, extending a decline from its …
LATEST NEWS
